HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Left ventricular outflow tract obstruction unmasked by nifedipine: a therapeutic pitfall in the management of chronic aortic regurgitation.

Abstract
This case report illustrates the aggravation of a clinically silent left ventricular outflow tract obstruction by maintenance use of nifedipine in a patient with chronic severe aortic regurgitation, and demonstrates a potential limitation of vasodilator therapy in the management of this patient population. Recognition of this clinical scenario is imperative, as decision making in patients with chronic severe aortic regurgitation rests on the development of symptoms and/or left ventricular dysfunction in relation to the regurgitant volume. The importance of echocardiography in the detection of this valvular finding and in the follow up of these patients is emphasized.
AuthorsG M Novaro, L L Rodriguez
JournalThe Journal of heart valve disease (J Heart Valve Dis) Vol. 10 Issue 5 Pg. 691-3 (Sep 2001) ISSN: 0966-8519 [Print] England
PMID11603612 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vasodilator Agents
  • Nifedipine
Topics
  • Aortic Valve Insufficiency (complications, diagnosis, drug therapy)
  • Chronic Disease
  • Echocardiography
  • Humans
  • Male
  • Middle Aged
  • Nifedipine (adverse effects)
  • Vasodilator Agents (adverse effects)
  • Ventricular Dysfunction, Left (complications, drug therapy)
  • Ventricular Outflow Obstruction (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: